Greer has finished enrolling patients for its Phase III clinical trial studying sublingual-oral immunotherapy as a treatment for adults with allergic rhinoconjunctivitis caused by short ragweed pollen.
Read More
DOR BioPharma is collaborating with Numoda, a clinical trials information services company, in its upcoming confirmatory Phase III clinical trial of orBec in the treatment of gastrointestinal graft-versus-host disease (GI GVHD).
Read More
Mpex Pharmaceuticals has begun a Phase II clinical study with MP-376 for the treatment of pulmonary infections in patients with cystic fibrosis (CF).
Read More
MethylGene has initiated a Phase II clinical trial evaluating MGCD0103 in combination with injections of Vidaza for patients with high-risk myelodysplastic syndromes or acute myeloid leukemia.
Read More
GPC Biotech is beginning a clinical trial testing satraplatin combined with the steroid prednisone in patients with metastatic hormone-refractory prostate cancer who have been treated with docetaxel, a chemotherapy drug.
Read More
A Phase II clinical trial is under way for BioMarck Pharmaceuticals’ study of BIO-11006 inhalation solution for chronic obstructive pulmonary disease (COPD).
Read More
Clinical Trial Inspections: How to Prevent a Bad Outcome is brought to you by RxTrials Institute. Discover how to confidently navigate the FDA’s inspectional process: before, during and after a GCP inspection. Use the clinical trial compliance tool created by a former FDA inspector, customize an auditing checklist and capture your most critical endpoint data, and put best practices to work when auditing and training your research staff.
Read More
